Laurus Labs acquires additional stake in Laurus Bio

21 Nov 2023 Evaluate

Laurus Labs has completed the acquisition of balance 8,333 equity shares from the promoter group shareholders of Laurus Bio on November 20, 2023. With this acquisition the Company holds 87.59% shareholding (on fully diluted basis) in Laurus Bio.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

1000.50 -25.00 (-2.44%)
09-Mar-2026 11:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1789.15
Dr. Reddys Lab 1287.90
Cipla 1313.95
Zydus Lifesciences 896.00
Lupin 2312.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×